Vaccine Progress and What’s Next
Goldman Sachs Exchanges - Un pódcast de Goldman Sachs - Martes
Categorías:
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
